Transplant may benefit patients with tumors of gastroentero-pancreatic origin Healio The study analyzed 215 consecutive patients referred for liver transplantation with hepatic metastases from neuroendocrine tumors of gastroentero-pancreatic origin (GEP-NET) during a 13-year period at a single institution. Median follow-up was 95 months. |
